Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study

Psychiatric comorbidity is frequent in rheumatoid arthritis (RA) and complicates treatment. The present study was undertaken to describe the impact of psychiatric comorbidity on health care use (utilization) in RA.

[1]  Anatomical Therapeutic Chemical Classification System , 2020, Definitions.

[2]  G. Kaplan,et al.  Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis. , 2020, The American journal of gastroenterology.

[3]  Jennifer M. Hensel,et al.  Economic Burden of Depression and Associated Resource Use in Manitoba, Canada , 2019, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[4]  Der-Yuan Chen,et al.  Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan , 2019, Front. Pharmacol..

[5]  J. Sareen,et al.  Examining the cross-sectional and longitudinal effects of anxiety sensitivity on indicators of disease severity among patients with inflammatory arthritis. , 2019, Journal of anxiety disorders.

[6]  Jill R. Glassman,et al.  Effects of Mental Health on the Costs of Care for Chronic Illnesses. , 2019, Psychiatric services.

[7]  Nan Li,et al.  The economic burden of depression among adults with rheumatoid arthritis in the United States , 2019, Journal of medical economics.

[8]  I. McInnes,et al.  Rheumatoid arthritis and depression: an inflammatory perspective. , 2019, The lancet. Psychiatry.

[9]  L. Lix,et al.  Prevalence and Incidence of Rheumatoid Arthritis in Canadian First Nations and Non–First Nations People , 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[10]  A. Guérin,et al.  Economic burden of relapse/recurrence in patients with major depressive disorder , 2019, Journal of drug assessment.

[11]  P. Jousilahti,et al.  30-year trends in asthma and the trends in relation to hospitalization and mortality. , 2018, Respiratory medicine.

[12]  L. Lix,et al.  Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. , 2018, General hospital psychiatry.

[13]  L. Lix,et al.  Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis , 2018, Arthritis care & research.

[14]  J. Mahlich,et al.  Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data , 2018, Rheumatology and Therapy.

[15]  Li Wang,et al.  Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs , 2018, Rheumatology advances in practice.

[16]  L. Lix,et al.  Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease , 2017, Epidemiology and Psychiatric Sciences.

[17]  J. Hanly,et al.  A Longitudinal Study of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Patients with Rheumatoid Arthritis: A 13-year Population Health Study , 2017, The Journal of Rheumatology.

[18]  L. Lix,et al.  Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. , 2017, Journal of psychosomatic research.

[19]  A. V. van Balkom,et al.  Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials , 2017, British Medical Journal.

[20]  N. Bansback,et al.  Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis , 2017, Current Rheumatology Reports.

[21]  R. Marrie,et al.  Health care utilisation before and after intensive care unit admission in rheumatoid arthritis. , 2017, Clinical and experimental rheumatology.

[22]  Hyon K. Choi,et al.  Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011 , 2017, Arthritis care & research.

[23]  R. Timman,et al.  Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? , 2017, PloS one.

[24]  R. D. de Bie,et al.  Impact of Chronic Diseases and Multimorbidity on Health and Health Care Costs: The Additional Role of Musculoskeletal Disorders , 2016, Arthritis care & research.

[25]  Jean-Marie Bamvita,et al.  Implementation of the Quebec mental health reform (2005–2015) , 2016, BMC Health Services Research.

[26]  E. Keystone,et al.  Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. , 2016, Rheumatology.

[27]  Guangming Han,et al.  Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis , 2016, Clinical Rheumatology.

[28]  Raveendhara R. Bannuru,et al.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis care & research.

[29]  E. Matteson,et al.  Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota. , 2015, Mayo Clinic proceedings.

[30]  Nancy Xiaonan Yu,et al.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis , 2014, Neurology.

[31]  C. Wolfson,et al.  Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance , 2013, BMC Neurology.

[32]  M. Englund,et al.  Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population , 2012, Annals of the rheumatic diseases.

[33]  M. Fleury,et al.  Management of mental health problems by general practitioners in Quebec. , 2012, Canadian family physician Medecin de famille canadien.

[34]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[35]  Dan Chateau,et al.  Learning from the census: the Socio-economic Factor Index (SEFI) and health outcomes in Manitoba. , 2012, Canadian journal of public health = Revue canadienne de sante publique.

[36]  David Reeves,et al.  The Role of Primary Care in Service Provision for People with Severe Mental Illness in the United Kingdom , 2012, PloS one.

[37]  Ashutosh Kumar Singh,et al.  Hidden Cost of Rheumatoid Arthritis (RA): Estimating Cost of Comorbid Cardiovascular Disease and Depression Among Patients with RA , 2009, The Journal of Rheumatology.

[38]  H. Macdonald,et al.  Mental health care in the primary care setting: family physicians' perspectives. , 2008, Canadian family physician Medecin de famille canadien.

[39]  W. Iacono,et al.  Risk for recurrence in depression. , 2007, Clinical psychology review.

[40]  Josep Maria Haro,et al.  Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys , 2007, The Lancet.

[41]  A. G. Witney,et al.  The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis. , 2006, Rheumatology.

[42]  R. Reid,et al.  Population-based use of mental health services and patterns of delivery among family physicians, 1992 to 2001. , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[43]  R. Sturm,et al.  Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs. , 2005, Psychiatric services.

[44]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[45]  Raveendhara R. Bannuru,et al.  American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2015 .

[46]  Daniel J. Bauer,et al.  The disaggregation of within-person and between-person effects in longitudinal models of change. , 2011, Annual review of psychology.